References
- Mehndiratta MM, Mehndiratta P, Phul P, et al. Valproate induced non hepatic hyperammonaemic encephalopathy (VNHE)—a study from tertiary care referral university hospital, North India. J Pak Med Assoc 2008;58:627-31
- Lheureux PE, Penaloza A, Zahir S, et al. Science review: carnitine in the treatment of valproic acid-induced toxicity - what is the evidence? Crit Care 2005;9:431-40
- Bowden CL, Singh V. Valproate in bipolar disorder: 2000 onwards. Acta Psychiatr Scand Suppl 2005;426:13-20
- Lheureux PE, Hantson P. Carnitine in the treatment of valproic acid-induced toxicity. Clin Toxicol (Phila) 2009;47:101-11
- Bowden CL, Karren NU. Anticonvulsants in bipolar disorder. Aust N Z J Psychiatry 2006;40:386-93
- Chou HF, Yang RC, Chen CY, et al. Valproate-induced hyperammonemic encephalopathy. Pediatr Neonatol 2008;49:201-4
- Coulter DL, Allen RJ. Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy. Lancet 1980;1:1310-11
- Segura-Bruna N, Rodriguez-Campello A, Puente V, et al. Valproate-induced hyperammonemic encephalopathy. Acta Neurol Scand 2006;114:1-7
- Carr RB, Shrewsbury K. Hyperammonemia due to valproic acid in the psychiatric setting. Am J Psychiatry 2007;164:1020-7
- Murphy JV, Marquardt K. Asymptomatic hyperammonemia in patients receiving valproic acid. Arch Neurol 1982;39:591-2
- Coude FX, Rabier D, Cathelineau L, et al. A mechanism for valproate-induced hyperammonemia. Adv Exp Med Biol 1982;153:153-61
- Dealberto MJ. Valproate-induced hyperammonaemic encephalopathy: review of 14 cases in the psychiatric setting. Int Clin Psychopharmacol 2007;22:330-7
- Raja M, Azzoni A. Valproate-induced hyperammonaemia. J Clin Psychopharmacol 2002;22:631-3
- Verrotti A, Trotta D, Morgese G, et al. Valproate-induced hyperammonemic encephalopathy. Metab Brain Dis 2002;17:367-73
- Wadzinski J, Franks R, Roane D, et al. Valproate-associated hyperammonemic encephalopathy. J Am Board Fam Med 2007;20:499-502
- Mock CM, Schwetschenau KH. Levocarnitine for valproic-acid-induced hyperammonemic encephalopathy. Am J Health Syst Pharm 2012;69:35-9
- Ziyeh S, Thiel T, Spreer J, et al. Valproate-induced encephalopathy: assessment with MR imaging and 1H MR spectroscopy. Epilepsia 2002;43:1101-5
- Raskind JY, El-Chaar GM. The role of carnitine supplementation during valproic acid therapy. Ann Pharmacother 2000;34:630-8
- Gidal BE, Inglese CM, Meyer JF, et al. Diet- and valproate-induced transient hyperammonemia: effect of L-carnitine. Pediatr Neurol 1997;16:301-5
- De Vivo DC, Bohan TP, Coulter DL, et al. L-carnitine supplementation in childhood epilepsy: current perspectives. Epilepsia 1998;39:1216-25